​

Kalaris Therapeutics Ownership | Who Owns Kalaris Therapeutics?

OverviewChart

Kalaris Therapeutics Ownership Summary

Kalaris Therapeutics is owned by 74.18% institutional investors, and 25.82% retail investors.

KLRS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKalaris Therapeutics74.18%-25.82%
SectorHealthcare Stocks 79.60%10.14%10.26%
IndustryBiotech Stocks 63.99%10.18%25.83%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202531-13,874,350-74-31---

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1-1

KLRS Ownership FAQ

Who Owns Kalaris Therapeutics?

Kalaris Therapeutics shareholders are primarily institutional investors at 74.18%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Kalaris Therapeutics's industry, Biotech Stocks , is 63.99%, which Kalaris Therapeutics exceeds.

Does Blackrock own Kalaris Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Kalaris Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools